Innovative
Therapeutics for
Better Health
Because Life
Shouldn't Have to
Wait for Migraines
Our Lead Product Candidate
STS101
Dihydroergotamine (DHE) Nasal Powder
Learn More
Clinical Trials
SUMMIT™ Trial
Currently Recruiting
Learn More
Press Releases
Sep 08, 2021
Satsuma Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Read More
Aug 10, 2021
Satsuma Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Business Highlights
Read More
